Peter Earls
Papers
1
Total Citations
10
H-Index
1
About
Driven by a commitment to improving outcomes for head and neck cancer patients, Peter Earls has established himself as a leading voice in the surgical management of HPV-associated oropharyngeal squamous cell carcinoma (OPSCC). His research centers on the application and evaluation of transoral robotic surgery (TORS), a minimally invasive technique that reduces recovery time and morbidity. In his landmark 2024 study, "Oncological outcomes post transoral robotic surgery (TORS) for HPV-associated oropharyngeal squamous cell carcinoma," Earls presents a comprehensive 10-year retrospective analysis from a major Australian centre. This pivotal work, which has already garnered 10 citations, provides critical evidence on the long-term oncological safety and efficacy of TORS for this specific patient population. By meticulously reviewing a large cohort, Earls demonstrates that primary surgical treatment can achieve excellent disease control while preserving quality of life. His findings are instrumental in shaping clinical guidelines and offering surgeons a robust framework for patient selection and counselling. Through this rigorous, real-world data, Peter Earls is helping to solidify TORS as a cornerstone therapy for HPV-driven oropharyngeal cancers, directly influencing surgical practice in Australia and beyond.
Research Focus
Key Achievements
Top Papers
- 1